{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:40:00Z","timestamp":1793695200888,"version":"4.5.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":5154,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/labinvest.2008.90","type":"journal-article","created":{"date-parts":[[2008,9,15]],"date-time":"2008-09-15T11:59:06Z","timestamp":1221479946000},"page":"1329-1339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model"],"prefix":"10.1016","volume":"88","author":[{"given":"Nagasuresh","family":"Adapala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion M","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2008.90_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.ATV.0000133606.69732.4c","article-title":"Lipid inflammatory mediators in diabetic vascular disease","volume":"24","author":"Natarajan","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/labinvest.2008.90_bib2","series-title":"Phytopharmaceuticals in Cancer Chemoprevention","first-page":"349","article-title":"Curcumin derived from Turmeric (Curcuma longa): a spice for all seasons","author":"Aggarwal","year":"2005"},{"key":"10.1038\/labinvest.2008.90_bib3","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.lfs.2005.12.017","article-title":"Dietary supplements and related products: a brief summary","volume":"78","author":"Rapaka","year":"2006","journal-title":"Life Sci"},{"key":"10.1038\/labinvest.2008.90_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/aje\/kwh207","article-title":"Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999\u20132000","volume":"160","author":"Radimer","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1038\/labinvest.2008.90_bib5","first-page":"912","article-title":"Complementary and alternative medicine; assessing the evidence for immunological benefits","volume":"4","author":"Goldrosen","year":"2004","journal-title":"Nature"},{"key":"10.1038\/labinvest.2008.90_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0885066604267854","article-title":"Serious infections associated with anticytokine therapies in the rheumatic diseases","volume":"19","author":"Giles","year":"2004","journal-title":"J Intensive Care Med"},{"key":"10.1038\/labinvest.2008.90_bib7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s10067-006-0356-5","article-title":"Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept","volume":"26","author":"Bagalas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1038\/labinvest.2008.90_bib8","first-page":"85","article-title":"Chemopreventive drug development: perspectives and progress","volume":"3","author":"Kelloff","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/labinvest.2008.90_bib9","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1038\/labinvest.2008.90_bib10","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0006-2952(95)00171-U","article-title":"Inhibition of tumor necrosis factor by curcumin, a phytochemical","volume":"49","author":"Chan","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.2008.90_bib11","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0006-2952(98)00114-2","article-title":"In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties","volume":"55","author":"Chan","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.2008.90_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.1995.1076","article-title":"Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages","volume":"206","author":"Brouet","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/labinvest.2008.90_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0304-3835(95)03913-H","article-title":"Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production","volume":"96","author":"Chan","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1038\/labinvest.2008.90_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/sj.bjp.0702803","article-title":"Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages","volume":"128","author":"Kang","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1038\/labinvest.2008.90_bib15","series-title":"Food Factors for Disease Prevention and Health Promotion","first-page":"86","article-title":"Modulation of cytokine gene expression by curcumin","author":"Chan","year":"2003"},{"key":"10.1038\/labinvest.2008.90_bib16","doi-asserted-by":"crossref","first-page":"G113","DOI":"10.1152\/ajpgi.00200.2006","article-title":"Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells","volume":"292","author":"Zheng","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2008.90_bib17","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1073\/pnas.1031789100","article-title":"PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages","volume":"100","author":"Welch","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2008.90_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-2006-946680","article-title":"Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma","volume":"72","author":"Rau","year":"2006","journal-title":"Planta Med"},{"key":"10.1038\/labinvest.2008.90_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb Pathog"},{"key":"10.1038\/labinvest.2008.90_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","article-title":"Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis","volume":"20","author":"Engwerda","year":"2004","journal-title":"Trends Parasitol"},{"key":"10.1038\/labinvest.2008.90_bib21","series-title":"PDR for Herbal Medicines","first-page":"786","author":"Gruenwald","year":"1998"},{"key":"10.1038\/labinvest.2008.90_bib22","first-page":"62","article-title":"Epidemiology of visceral leishmaniasis in India","volume":"12","author":"Bora","year":"1999","journal-title":"Natl Med J India"},{"key":"10.1038\/labinvest.2008.90_bib23","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1111\/j.1753-4887.1996.tb03832.x","article-title":"Indian functional foods: role in prevention of cancer","volume":"54","author":"Krishnaswamy","year":"1996","journal-title":"Nutr Rev"},{"key":"10.1038\/labinvest.2008.90_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00436-005-1323-9","article-title":"Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania","volume":"1","author":"Chan","year":"2005","journal-title":"Parasitol Res"},{"key":"10.1038\/labinvest.2008.90_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol"},{"key":"10.1038\/labinvest.2008.90_bib26","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JCM.40.5.1666-1669.2002","article-title":"Real-time PCR for detection and quantitation of Leishmania in mouse tissues","volume":"40","author":"Nicolas","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1038\/labinvest.2008.90_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/labinvest.2008.90_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0923-2494(96)83011-2","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions","volume":"146","author":"Trinchieri","year":"1995","journal-title":"Res Immunol"},{"key":"10.1038\/labinvest.2008.90_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/labinvest.2008.90_bib30","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.4049\/jimmunol.145.12.4290","article-title":"Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-\u03b3-stimulated macrophages by induction of tumor necrosis factor-\u03b1","volume":"145","author":"Green","year":"1990","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2008.90_bib31","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-\u03b1 synergizes with IFN-\u03b3 in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2008.90_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.189.4.741","article-title":"Macrophage microbicidal mechanisms in vivo: reactive nitrogen vs oxygen intermediates in the killing of intracellular visceral Leishmania donovani","volume":"189","author":"Murray","year":"1999","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2008.90_bib33","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1038\/labinvest.2008.90_bib34","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect Immun"},{"key":"10.1038\/labinvest.2008.90_bib35","doi-asserted-by":"crossref","first-page":"G447","DOI":"10.1152\/ajpgi.00209.2004","article-title":"Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR","volume":"288","author":"Chen","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2008.90_bib36","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/01.CCM.0000221921.71300.BF","article-title":"The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma","volume":"34","author":"Siddiqui","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1038\/labinvest.2008.90_bib37","doi-asserted-by":"crossref","first-page":"G113","DOI":"10.1152\/ajpgi.00200.2006","article-title":"Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells","volume":"292","author":"Zheng","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2008.90_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/22572","article-title":"Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12\/15-lipoxygenase","volume":"400","author":"Huang","year":"1999","journal-title":"Nature"},{"key":"10.1038\/labinvest.2008.90_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2008.90_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2004.03.015","article-title":"Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro","volume":"68","author":"Gao","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.2008.90_bib41","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0035-9203(01)90218-4","article-title":"Leishmaniasis in Sudan. Visceral leishmaniasis","volume":"95","author":"Zijlstra","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1038\/labinvest.2008.90_bib42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1248\/bpb.25.386","article-title":"Latent activity of curcumin against leishmaniasis in vitro","volume":"25","author":"Saleheen","year":"2002","journal-title":"Biol Pharm Bull"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest200890.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest200890","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722018232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722018232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest200890.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:42:52Z","timestamp":1758397372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722018232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0023683722018232"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2008.90","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2008.90","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}